Ovarian cancer is a lethal gynecological cancer causing cancer-related deaths in women worldwide. It is difficult to diagnosis at an early stage when more than 90% patients can be cured because of lack of specific symptoms and early detection markers. Most of malignant ovarian tumors are originated from the germinal epithelium of the ovary. For investigation with animal models of epithelial-derived ovarian cancer (EOC), laying hens are the most relevant animal models because they spontaneously develop EOC as occurs in women through ovulating almost every day. As in women, EOC in the hen is age-related and grossly and histologically similar to that in women. However, domesticated animals are inappropriate for research human EOC due to multiple pregnancies and lactating or seasonally anestrous. In addition, the non-spontaneous nature of rodents EOC limits clinical relevance with human EOC. Recent studies have shown that ovarian cancer could arise from epithelium from the oviduct as oviduct-related genes are up-regulated in EOC of hens. Therefore, we showed in the review: 1) characterization and classification of EOC; 2) chicken models for EOC; 3) relationship estrogen with EOC; 4) candidate prognostic factors for EOC including serpin peptidase inhibior, clade B (ovalbumin), member 3 (SERPINB3), SERPINB11, gallicin 11 (GAL11), secreted phosphoprotein 1 (SPP1) and alpha 2 macroglobulin (A2M) in normal and cancerous ovaries of laying hens; 5) biological roles of microRNAs in development of EOC. Collectively, the present reviews indicate that expression of SERPINB3, SERPINB11, GAL11, SPP1 and A2M is clearly associated with the development of ovarian carcinogenesis. These results provide new insights into the prognostic biomarkers for EOC to diagnose and to evaluate responses to therapies for treating EOC of humans. (J Cancer Prev 2013;18:209-220) 
INTRODUCTION
Ovarian cancer is the most fatal gynecological carcinoma even though it is the 8 th most commonly diagnosed cancer and the 7 th leading cause of cancer-related deaths in women worldwide. 1 There are two hypothesis linked to carcinogenesis of ovaries, which indicate 'incessant ovulation' and 'gonadotropin' hypothesis. Incessant ovulation causes increase of epithelial ovarian cancer with the number of ovulation repeating ovarian rupture and repair. 2 And gonadotropin-related hypothesis provides that incidence rate of the ovarian cancer is increased by high levels of gonadotropin such as FSH and LH through stimulating the ovarian epithelium surface. 3 In a variety of previous studies, the first hypothesis related with spontaneous incessant ovulation has been reported having strong relationship with malignant transformation of ovaries.
Recently several studies have suggested alternative theory that aggressive ovarian carcinomas arise from the fallopian tube in women. 4, 5 Ovarian cancer can be classified to three cancerous types, epithelial carcinoma, sex-cord stromal carcinoma and germ cell carcinoma. 6, 7 More than 90% of human ovarian cancers are originated from ovarian surface epithelium.
And there are mainly four subtypes of epithelial-derived ovarian cancer that are serous (70%), endometrioid (10-20%), mucinous (3%) and clear cell (10%) carcinomas based on tumor cell morphology. 8 Furthermore, staging of human ovarian cancer is described by FIGO system from Stage I to IV with presence or absence of metastasis and ascites. Due to the lack of specific symptom and prognostic factors to diagnose ovarian cancer, most patients with this disease present advanced stage (Stage III or IV). 9, 10 This fact causes approximately 70% of patients with ovarian cancer to death. Therefore, it is important to develop the valuable early detection marker to diagnosis or treatment for ovarian cancers.
To investigate the mechanisms of target genes to develop as a biomarker, laying hens are relevant models because they spontaneously induce EOC at a high rate after stop egg production as occur in women whereas other animals including mammals and rodents are not develop spontaneous in nature for ovarian cancer. 11 Moreover, commonly used biomarkers to detect ovarian cancer clinically such as CA125 (also known as MUC16), epididymis protein 4 (HE4), proliferation markers including proliferating cell nuclear antigen (PCNA), vimentin, a proto-oncogene (ERBB2), a growth factor receptor (EGFR), a cell cycle inhibitor (p27), oncofetal tumor markers (CEA, Lewis Y and Tag 72) and TGF-α are expressed in chicken ovarian cancer, too. [12] [13] [14] In addition, histological appearance of EOC of chicken is similar to those of humans. 15 Therefore, avian model is the best for determination of oncogenic mechanisms.
In this regard, to discover the prognostic factors for diagnosis and treatment of EOC, we reviewed the characteristics, classification and experimental models for EOC and relationship estrogen and genetic regulation including SERPINB3, SERPINB11, GAL11, SPP1, and A2M genes with development of female reproductive tract and those of disease. In addition, we determined the biological roles of microRNA in development of EOC.
CHARACTERIZATION AND CLASSIFICATION OF OVARIAN CANCER
The histologic classification categorized ovarian carcinomas according to derivation from coelomic surface epithelium, germ cells, and sex-cord stromal cells. 6, 7 Among the rest, the majority human malignant ovarian cancers are germinal epithelium of the ovary. and BRAF (6.3%). [31] [32] [33] [34] In addition, these type of tumor are associated with over-expression of numerous genes such as HFF1 homeobox 1B (HNF-1B), SPP1, neuraminidase 3 (NEU3) and annexin A4. 35, 36 Recent studies based on clinicopathologic and molecular They show high frequency of TP53 gene mutations, which are indicated rarely in the type I tumors. 45 Furthermore, approximately 50% of high-grade serous carcinomas is related in molecular alteration of BRCA by the gene mutation or by methylation of BRCA promoter. 46 
CHICKEN MODEL FOR EPITHELIAL-DERIVED OVARIAN CANCER
The majority of women diagnosed at an advanced stage of EOC have a high probability of dying from the disease. EOC is associated with complex genetic and epigenetic alterations leading to ovarian cancer. Thus, it is very important to identify mechanism leading to initiation, promotion and progression of EOC. It is difficult to establish etiologies and pathogenesis of EOC in women; therefore, exploitation of animal models for EOC is essential.
The laying hen is a valuable model for investigation of EOC because they develop EOC spontaneously at a high rate after producing eggs when more than two years of age.
Similarly, natural menopause usually arises between 40-and 55-years of age in women when production of female steroid hormones, estrogen and progesterone, is decreasing with advancing age of their ovaries. Incessant ovulation in laying hens (almost every day) and women (once a month) is considered the major causative factor of EOC. 11, 15, 47 Ovarian carcinomas of the laying hen model presents histopathologically with serous, endometrioid, mucinous and clear cell carcinomas as occurs in women. Furthermore, the stages of ovarian cancer in laying hens are similar to that for EOC in women based on the following FIGO system classifications. 10, 15 
ESTROGEN ACTION IN THE EPITHELIAL-DERIVED OVARIAN CANCER
Estrogen is the most important steroid hormone in the avian female reproductive tract as a primary sex hormone.
In general, estrogen plays crucial roles in the modification of several cell-types with respect to development and differentiation, altering expression of specific genes in a variety of organs, and regulation of various biological events including protection against apoptosis, osteoporosis, diabetes and Alzheimer's disease. [50] [51] [52] For these biological actions, estrogen binds two classical nuclear receptors, estrogen alpha (ESR1) and beta (ESR2). On the other hand, the exact mechanisms of estrogen action are unknown regarding development of ovarian cancer. Therefore, advanced studies are required to verify the relationship between estrogenic activity and expression of its receptors and the etiology and pathogenesis of EOC.
CANDIDATE BIOMARKERS FOR EPITHELIAL-DERIVED OVARIAN CANCER 1. A2M
The alpha 2 macroglobulins (A2M) function as protease inhibitors in serum of mammals and are able to bind a variety of cytokines and growth factors. [69] [70] [71] [72] Proteases and their inhibitors take part in various biological events such as oncogenesis and metastasis because of their capacity to degrade extracellular matrix proteins. 73 Similar to other protease inhibitors, A2M is increased in plasma of women with inflammatory and neoplastic lesions of the ovary. 74 In addition, A2M increases in blood of laying hens more than 6 months prior to detection of advanced-stage EOC whereas A2M suppresses DNA synthesis in mouse ovarian tumor cells as a cytotoxic factor in serum. [75] [76] [77] These results suggest that increased levels of A2M in plasma of laying hens develop in the late-stages of ovarian cancer as compared with its concentration in serum of normal laying hens. 77 According to various lines of evidence, A2M might be a novel biomarker for improvements in early detection of ovarian cancer.
GAL11
GAL11 (also known as beta-defensin 11; DEFB11) belongs to avian defensins that are members of the beta-defensin subfamily members that exhibit antimicrobial activity against microbes including gram-positive/-negative bacteria or fungi. 24, [78] [79] [80] Avian beta defensing genes identified in chicken leukocytes can be subdivided into 14 classes. 81 Among them, GAL11 expression increases significantly in response to lipopolysaccharides 82 and DES 83 in chicken.
In mammals, there are several reports on identification of the role of beta-defensins in carcinogenesis. First of all, the low expression of human beta-defensin 1 (DEFB1) is involved in renal cell carcinomas, prostate cancer, basal cell carcinomas and oral squamous cell carcinomas as a tumor suppressor. [84] [85] [86] And overexpression of DEFB3 increases development of oral cancer through recruitment of macrophages via EGF that induces DEFB3 expression. 87 In addition, DEFB2 and DEFB3 function as proto-oncogenes in oral squamous cell carcinomas, whereas DEFB1 works as a tumor suppressor gene. 88 Moreover, GAL11 was induced in the cancerous ovaries compared with normal ovaries of chicken. With these results, it is possible to suggest that beta-defensins influence carcinogenesis through alteration of inflammation and cytokine production.
SERPINB3
SERPINB3, also known as squamous cell carcinoma 1 (SCCA1), was discovered originally in squamous cell carcinoma of the cervix. 89 It belongs to the serpin su- In addition, in apoptosis mechanisms, SERPINB3 is upstream of caspase-3, one of its molecular targets, which attenuates caspase-3 activity and apoptosis. 94 Moreover, SERPINB3 specifically modulates activity of c-Jun NH2-terminal kinase-1 (JNK-1). 95 In chicken ovarian cancer, SERPINB3 mRNA and protein were localized in the glandular epithelium of cancerous ovaries. And it was abundant in the nucleus of both chicken and human ovarian cancer cell lines. Moreover, in 109 human patients with EOC, SERPINB3 protein was showed weak (13.8%), moderate (60.6%), and strong (25.7%) expression respectively. 96 Therefore, SERPINB3 may play a crucial role in EOC and be a novel biomarker for prognosis for EOC.
SERPINB11
SERPINBs are one of group in the serpin superfamily of serine and cysteine proteinase inhibitors having crucial roles in various biological events such as blood coagulation, angiogenesis, inflammation and fibrinolysis. 97 Most clade B serpin genes are intracellular proteins that primarily suppress target proteases whereas SERPINB5 and SERPINB11 are intracellular non-inhibitory proteins. invasion, migration and proliferation of the cancer cells. [126] [127] [128] [129] In chickens, several microRNAs were reported to regulate expression of their target genes that are related in the development of EOC (Table 1) . [130] [131] [132] In accordance with previous studies, the cancer-related 
